Omega-3 polyunsaturated fatty acids and gut microbiota

Area of Science:

• Microbiology
• Nutrition Science
• Gastroenterology

Background:

• Oral intake of omega-3 polyunsaturated fatty acids (PUFAs) is linked to alterations in gut microbiota composition.
• Recent research investigates the role of these microbial changes in mediating the health benefits of n-3 PUFAs.

Purpose of the Study:

• To review recent findings (2024 onwards) on how changes in gut bacteria and their metabolites contribute to the health effects of n-3 PUFAs.
• To build the scientific case for the gut microbiota's role in n-3 PUFA activity.

Main Methods:

• Review of recent scientific literature from 2024 onwards.
• Analysis of rodent disease models, human intervention and observational studies.
• Examination of fecal transplantation experiments and in-vitro colonic models.

Main Results:

• n-3 PUFAs alter the abundance of specific gut bacterial species involved in short-chain fatty acid synthesis, but not overall diversity, in a model-specific manner.
• Fecal transplantation studies in rodents confirm a causal link between n-3 PUFA-induced microbiota changes and disease phenotype reversal.
• In-vitro models are being employed to elucidate the mechanisms of n-3 PUFA-induced gut microbiota and metabolome alterations.

Conclusions:

• Emerging evidence suggests the gut microbiota mediates n-3 PUFA effects in animal models.
• Human data are currently sparse, and the precise mechanisms by which n-3 PUFAs influence gut microbiota remain unclear.
• Further research is needed to understand n-3 PUFA metabolism by gut microbes and its contribution to the host metabolome.